François M. Vallette

17.7k total citations · 3 hit papers
178 papers, 9.2k citations indexed

About

François M. Vallette is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, François M. Vallette has authored 178 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Molecular Biology, 36 papers in Cancer Research and 31 papers in Oncology. Recurrent topics in François M. Vallette's work include Cell death mechanisms and regulation (51 papers), Mitochondrial Function and Pathology (28 papers) and Epigenetics and DNA Methylation (25 papers). François M. Vallette is often cited by papers focused on Cell death mechanisms and regulation (51 papers), Mitochondrial Function and Pathology (28 papers) and Epigenetics and DNA Methylation (25 papers). François M. Vallette collaborates with scholars based in France, United Kingdom and United States. François M. Vallette's co-authors include Pierre‐François Cartron, Lisa Oliver, Jean Massoulié, Philippe Juin, Suzanne Bon, Lisenn Lalier, Leo Pezzementi, Éric Krejci, Stéphen Manon and Khaled Méflah and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

François M. Vallette

177 papers receiving 9.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular and cellular biology of cholinesterases

1993 1.0k citations Jean Massoulié, Leo Pezzementi et al. Progress in Neurobiology profile →
The Mitochondrial Pathways of Apoptosis

2011 515 citations François M. Vallette et al. profile →
Three-dimensional in vitro culture models in oncology research

2022 161 citations François M. Vallette, Lisa Oliver et al. profile →

Peers

Countries citing papers authored by François M. Vallette

Since Specialization

Citations

This map shows the geographic impact of François M. Vallette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François M. Vallette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François M. Vallette more than expected).

Fields of papers citing papers by François M. Vallette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François M. Vallette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François M. Vallette. The network helps show where François M. Vallette may publish in the future.

Co-authorship network of co-authors of François M. Vallette

This figure shows the co-authorship network connecting the top 25 collaborators of François M. Vallette. A scholar is included among the top collaborators of François M. Vallette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François M. Vallette. François M. Vallette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Spatial Distribution of Immune Cells in Primary and Recurrent Glioblastoma: A Small Case Study	Cancers	Delphine Loussouarn, Lisa Oliver et al.	7
2	A Simple 3D Cell Culture Method for Studying the Interactions between Human Mesenchymal Stromal/Stem Cells and Patients Derived Glioblastoma	Cancers	Lisa Oliver, Gabriel F. Calvo et al.	3
3	Low-Dose Pesticides Alter Primary Human Bone Marrow Mesenchymal Stem/Stromal Cells through ALDH2 Inhibition	Cancers	Frédéric Picou, Nathalie Gallay et al.	10
4	Mitochondria transfer from tumor-activated stromal cells (TASC) to primary Glioblastoma cells	Biochemical and Biophysical Research Communications	Juan Belmonte-Beitia, Gabriel F. Calvo et al.	60
5	N6-Adenosine Methylation of miRNA-200b-3p Influences Its Functionality and Is a Theranostic Tool	Molecular Therapy — Nucleic Acids	Aurélien A. Sérandour, Arulraj Nadaradjane et al.	9
6	NKG2D Controls Natural Reactivity of Vγ9Vδ2 T Lymphocytes against Mesenchymal Glioblastoma Cells	Clinical Cancer Research	Cynthia Chauvin, Noémie Joalland et al.	30
7	Impairing temozolomide resistance driven by glioma stem‐like cells with adjuvant immunotherapy targeting O‐acetyl GD2 ganglioside	International Journal of Cancer	Julien Fleurence, Sophie Fougeray et al.	25
8	The TET2 Expression Level Correlates with a Short Relapse Time in Glioblastoma Multiforme	HAL (Le Centre pour la Communication Scientifique Directe)	Arulraj Nadaradjane, François M. Vallette et al.	1
9	Sensitization of EGFR Wild-Type Non–Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor Erlotinib	Molecular Cancer Therapeutics	Judith Raimbourg, Marie‐Pierre Joalland et al.	17
10	Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity	Clinical Cancer Research	Kristell Oizel, Cynthia Chauvin et al.	71
11	Histone H3 Phosphorylation in GBM: a New Rational to Guide the Use of Kinase Inhibitors in anti-GBM Therapy	Theranostics	Mathilde Cheray, Arulraj Nadaradjane et al.	36
12	Prognostic impact of the expression/phosphorylation of the BH3-only proteins of the BCL-2 family in glioblastoma multiforme	Cell Death and Disease	Pierre‐François Cartron, Delphine Loussouarn et al.	37
13	Bax activation by engagement with, then release from, the BH3 binding site of Bcl-xL.	HAL (Le Centre pour la Communication Scientifique Directe)	France Gauthier, Pierre‐François Cartron et al.	2
14	Bax Activation by Engagement with, Then Release from, the BH3 Binding Site of Bcl-x _L	Molecular and Cellular Biology	Fabien Gautier, Yannis Guillemin et al.	30
15	Folate Supplementation Limits the Aggressiveness of Glioma via the Remethylation of DNA Repeats Element and Genes Governing Apoptosis and Proliferation	Clinical Cancer Research	Éric Hervouet, Emilie Debien et al.	59
16	Tolerance analysis in MOSFET analog integrated circuits	International Conference on Systems	François M. Vallette, Patrick Garda et al.	1
17	Impairing the bioenergetic status and the biogenesis of mitochondria triggers mitophagy in yeast	Cell Death and Differentiation	Muriel Priault, Bénédicte Salin et al.	245
18	Impact of proapoptotic proteins Bax and Bak in tumor progression and response to treatment	Expert Review of Anticancer Therapy	Pierre‐François Cartron, Philippe Juin et al.	31
19	Evolution of Acetylcholinesterase Transcripts and Molecular Forms During Development in the Central Nervous System of the Quail	Journal of Neurochemistry	Alain Anselmet, Mireille Fauquet et al.	14
20	Molecular and cellular biology of cholinesterases breakdown →	Progress in Neurobiology	Jean Massoulié, Leo Pezzementi et al.	1046

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact